| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/05/1998 | CA2261823A1 Desaturase antigen of mycobacterium tuberculosis |
| 02/05/1998 | CA2261791A1 Boron neutron capture therapy using pre-targeting methods |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261575A1 Novel human macrophage antigen |
| 02/05/1998 | CA2261567A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 02/05/1998 | CA2261164A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | CA2261071A1 Assembly-deficient herpesvirus vaccine |
| 02/05/1998 | CA2259924A1 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/05/1998 | CA2232975A1 The nuca protein of haemophilus influenzae and the gene encoding that protein |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0821736A1 Bacteriocins |
| 02/04/1998 | EP0821735A1 Helicobacter pylori cagi region |
| 02/04/1998 | EP0821732A1 Altered polypeptides with increased half-life |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821698A1 Protective helicobacter antigens |
| 02/04/1998 | EP0821695A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
| 02/04/1998 | EP0821693A1 Novel human cytomegalovirus dna sequences |
| 02/04/1998 | EP0821692A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 02/04/1998 | EP0821591A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/04/1998 | EP0821583A1 Dna vaccines against rotavirus infections |
| 02/04/1998 | EP0671933B1 Novel uses of il-10 |
| 02/04/1998 | EP0652967B1 Self-assembling replication defective hybrid virus particles |
| 02/04/1998 | EP0651800B1 Basophil granule proteins |
| 02/04/1998 | EP0500791B1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 02/04/1998 | EP0460072B1 Human elastase inhibitor |
| 02/03/1998 | US5714596 NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
| 02/03/1998 | US5714593 Vaccines, medical diagnosis |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | US5714314 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method |
| 02/03/1998 | US5714167 Reversibly forming supramolecular complex of active agent with perturbant; drug delivery |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 02/03/1998 | US5714152 Herpes simplex virus VP16 vaccines |
| 02/03/1998 | US5714150 Method for producing extract of olive leaves |
| 02/03/1998 | US5714148 Chemical compounds |
| 02/03/1998 | US5714141 Use of interleukin 7 to enhance humoral immunity |
| 01/29/1998 | WO1998003873A1 Treatment and diagnosis of cancer |
| 01/29/1998 | WO1998003870A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 01/29/1998 | WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | WO1998003661A2 Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 01/29/1998 | WO1998003660A1 Feline polynucleotide vaccine formula |
| 01/29/1998 | WO1998003659A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | WO1998003658A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 01/29/1998 | WO1998003653A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 01/29/1998 | WO1998003635A1 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same |
| 01/29/1998 | WO1998003551A1 Cd6 ligand |
| 01/29/1998 | WO1998003550A1 Pasteurization of immunoglobulin solutions |
| 01/29/1998 | WO1998003544A1 IDENTIFICATION OF SHORT PEPTIDE SEQUENCES REPRESENTING EPITOPES OF GLYCOPROTEIN G OF HSV-2 USING A PHAGE PEPTIDE DISPLAY LIBRARY FOR USE IN AN ANTI-gG2 ELISA |
| 01/29/1998 | WO1998003543A1 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003200A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 01/29/1998 | WO1998003199A1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases |
| 01/29/1998 | WO1998003198A1 Polynucleotide vaccine formula for treating horse diseases |
| 01/29/1998 | WO1998003197A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
| 01/29/1998 | WO1998003196A1 Intradermal bovine polynucleotide vaccine |
| 01/29/1998 | WO1998003081A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 01/29/1998 | WO1997047732A3 Hexameric fusion proteins and uses therefor |
| 01/29/1998 | WO1997046253A3 Immunotherapy for autoimmune disease |
| 01/29/1998 | WO1997044463A3 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 01/29/1998 | DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use |
| 01/29/1998 | CA2262007A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
| 01/29/1998 | CA2261898A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 01/29/1998 | CA2261343A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | CA2261291A1 Pasteurization of immunoglobulin solutions |
| 01/29/1998 | CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | CA2258872A1 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 01/29/1998 | CA2232142A1 Cd6 ligand |
| 01/28/1998 | EP0821060A2 Diagnosis and therapy of human malign tumors based on E-cadherin mutations |
| 01/28/1998 | EP0820590A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals |
| 01/28/1998 | EP0820515A1 Phospholipase c homolog |
| 01/28/1998 | EP0820510A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors |
| 01/28/1998 | EP0820472A1 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 01/28/1998 | EP0820471A1 Antibodies against heart muscle actin |
| 01/28/1998 | EP0820470A1 Novel anti-aids immunotoxins |
| 01/28/1998 | EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 01/28/1998 | EP0820311A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface |
| 01/28/1998 | EP0820309A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 01/28/1998 | EP0820305A2 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| 01/28/1998 | EP0820304A1 Chlamydia vaccines |
| 01/28/1998 | EP0820303A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 01/28/1998 | EP0752886B1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/28/1998 | CN1171814A Polynucleotide tuberculosis vaccine |
| 01/28/1998 | CN1171813A Delivery system |
| 01/27/1998 | US5712370 Erythropoietin (EPO) peptides and antibodies directed against these |
| 01/27/1998 | US5712245 Protection against infection |
| 01/27/1998 | US5712155 DNA encoding tumor necrosis factor-α and -β receptors |
| 01/27/1998 | US5712143 Polypeptide |
| 01/27/1998 | US5712120 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 01/27/1998 | US5712118 Vaccine for branhamella catarrhalis |
| 01/27/1998 | US5712104 Screening test for cancer, aids/hiv, influenza |
| 01/27/1998 | US5712102 Method of screening compounds which inhibit P. gingivalis lipopolysaccharide from inhibiting the extravasation of leukocytes |
| 01/27/1998 | US5712101 Glycosylation of hemoglobin, quantification, reaction with epitopes for detection of diabetes |
| 01/27/1998 | US5711949 Vision improving eye solution |
| 01/27/1998 | US5711947 Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides |
| 01/26/1998 | CA2182046A1 Haemophilus adhesin protein |
| 01/22/1998 | WO1998002749A1 Method of predicting resistance to hepatitis c infection |
| 01/22/1998 | WO1998002740A1 Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
| 01/22/1998 | WO1998002552A2 Vaccine compositions |
| 01/22/1998 | WO1998002548A2 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | WO1998002547A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/22/1998 | WO1998002546A2 Dna immunization against chlamydia infection |